Takeaway
- Patients with chronic lymphocytic leukemia (CLL) may experience a poor antibody-mediated response to COVID-19 vaccines.
Why this matters
- Previous studies involving pneumococcal, hepatitis B, and influenza A and B vaccinations have shown that patients with CLL are likely to have compromised immune systems, resulting in a poor response to vaccines....
